Research and Markets: Global Malignant Glioma Pipeline Review 2015

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/lht3pl/malignant_glioma) has announced the addition of the "Malignant Glioma - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Malignant Glioma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Malignant Glioma and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development

  • Advantagene, Inc.
  • Amgen Inc.
  • AstraZeneca Plc
  • BBB Therapeutics B.V.
  • Eisai Co., Ltd.
  • Eli Lilly and Company
  • Genmab A/S
  • Lipopharma Therapeutics SL
  • MediGene AG
  • Nuo Therapeutics, Inc.
  • Pfizer Inc.
  • Stemline Therapeutics, Inc.
  • Tiziana Life Sciences Plc
  • Vicus Therapeutics, LLC
  • ZIOPHARM Oncology, Inc.

For more information visit http://www.researchandmarkets.com/research/lht3pl/malignant_glioma

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology